Mission Street, a specialist investor, developer and operator for the science and innovation sector, and BGO, a global real estate investment manager, have signed AI-driven enzyme design company Xyme to the first purpose-built commercial science scheme in Oxford’s West End development.
Mission Street and BGO sign AI-powered science firm to Oxford labs
Xyme chooses Inventa for first major lease
By Luke Haynes
CoStar News
May 30, 2025 | 9:29 AM
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Bidwells LLP
Real Estate
- CBRE
Real Estate